Xiao-Hui Zheng Selected Research

Xiao-Hui Zheng Research Topics

Disease

14	Neoplasms (Cancer) 04/2022 - 10/2012
9	Nasopharyngeal Carcinoma 01/2021 - 07/2014
4	Ischemia 04/2022 - 02/2017
3	Carcinogenesis 01/2021 - 07/2014
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
2	Nasopharyngitis 01/2021 - 12/2018
2	Necrotizing Enterocolitis 07/2014 - 05/2011
1	Triple Negative Breast Neoplasms 07/2022
1	Infections 04/2022
1	Hepatocellular Carcinoma (Hepatoma) 04/2022
1	Heart Failure 02/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Ulcerative Colitis 01/2022
1	Duodenal Ulcer (Curling's Ulcer) 01/2022
1	Stomach Ulcer (Gastric Ulcer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 07/2021
1	Colorectal Neoplasms (Colorectal Cancer) 07/2021
1	Hand-Foot Syndrome 07/2021
1	Colonic Neoplasms (Colon Cancer) 07/2021
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2021
1	Leukemia 10/2017
1	Disease Progression 01/2016
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2015
1	Uterine Cervicitis (Cervicitis) 07/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2015
1	Osteoporosis 05/2014
1	Atherosclerotic Plaque (Atheroma) 01/2014
1	Esophageal Squamous Cell Carcinoma 12/2013
1	Hypoxia (Hypoxemia) 11/2011
1	Cicatrix (Scar) 11/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2004

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2013
4	RNA (Ribonucleic Acid)IBA 04/2022 - 11/2018
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2014
3	Biological ProductsIBA 01/2016 - 12/2013
2	Pharmaceutical PreparationsIBA 02/2022 - 10/2004
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2017 - 01/2016
2	Glutamine (L-Glutamine)FDA Link 07/2014 - 05/2011
1	Chalcone (Benzalacetophenone)IBA 07/2022
1	syringaldehyde (SYAL)IBA 07/2022
1	Oncostatin MIBA 01/2022
1	Dextran SulfateIBA 01/2022
1	Oncostatin M Receptors (Oncostatin M Receptor)IBA 01/2022
1	C1632IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 07/2021
1	piperlongumineIBA 07/2021
1	ProdrugsIBA 07/2021
1	Fluorouracil (Carac)FDA LinkGeneric 07/2021
1	Capecitabine (Xeloda)FDA Link 07/2021
1	Oleic Acid (Oleate)IBA 01/2021
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2021
1	LuciferasesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018
1	Nucleic AcidsIBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	ChromatinIBA 10/2017
1	AntioxidantsIBA 02/2017
1	PlatinumIBA 12/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	tetra(4-N-methylpyridyl)porphineIBA 01/2016
1	Photosensitizing Agents (Photosensitizers)IBA 01/2016
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 07/2015
1	VimentinIBA 07/2015
1	Fibronectins (Fibronectin)IBA 07/2015
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2015
1	CateninsIBA 07/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2014
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2014
1	Long Noncoding RNAIBA 12/2013
1	LipopolysaccharidesIBA 11/2011
1	NitrogenIBA 11/2011
1	Caspase 3 (Caspase-3)IBA 05/2011
1	Toll-Like Receptor 4IBA 05/2011
1	Hyaluronic Acid (Hyaluronan)IBA 11/2007
1	danshen dripping pillIBA 10/2004

Therapy/Procedure

4	Therapeutics 01/2022 - 10/2012
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Castration 07/2021
1	Radiotherapy 01/2020
1	Photochemotherapy (Photodynamic Therapy) 01/2016
1	Distraction Osteogenesis 05/2014
1	Nutritional Support (Artificial Feeding) 11/2011
1	Diskectomy (Discectomy) 11/2007